摘要
目的对比观察瑞舒伐他汀与阿托伐他汀治疗冠心病的临床效果。方法选取我院收治的100例冠心病患者作为本次研究的对象,随机分为对照组与观察组,每组50例患者,对照组采用阿托伐他汀治疗,观察组采用瑞舒伐他汀治疗,对比两组的治疗效果。结果对比两组病患治疗前后的总胆固醇、三酰甘油变化情况,观察组下降幅度优于对照组,具有统计学差异意义(P<0.05);两组患者在治疗过程中没有出现严重的不良反应情况。结论在对于冠心病的治疗中,采用瑞舒伐他汀比较阿托伐他汀临床治疗效果更显著,能有效改善病患血脂水平,延缓动脉硬化进程,值得在临床上推广使用。
Objective To study the clinical curative effect analysis of levofloxacin combined with metronidazole and anisodamine in treating chronic enteritis. Methods Select 86 cases of chronic enteritis patients in our hospital were given to the control group,intravenous infusion of levofloxacin therapy,if the patient does not appear to be served plus anisodamine,experimental group on the basis of oral metronidazole treatment.ResultsThe treatment of patients in the experimental group after treatment,the total effective rate was 93%,the recurrence rate was 4.7%,patients in the control group the total effective rate of treatment was 79.1%,recurrence rate was 18.6%,the treatment effect of experimental group was significantly better than the control group,the difference was significant （P〈0.05）,with statistical significance.Conclusion The use of levofloxacin,metronidazole and anisodamine in the treatment of chronic enteritis,can improve the therapeutic effect and effective,reduce the occurrence of complications,is conducive to improve the quality of life of patients,has high value in clinical application.
出处
《中国卫生标准管理》
2015年第6期236-236,共1页
China Health Standard Management
关键词
瑞舒伐他汀
阿托伐他汀
冠心病
Rosuvastatin
Atorvastatin
Coronary heart disease
